Antimicrobial Resistance of Shiga Toxin-Producing Escherichia Coli O157 Isolates from Northern Palestine

adwank's picture
Journal Title, Volume, Page: 
Emirates Medical Journal, 2004; 22: 249-250
Year of Publication: 
2004
Authors: 
Adwan G.M.
Department of Biological Sciences, An-Najah National University P O Box (7), Nablus, Palestine
Abu-Hasan N.S.
Department of Biological Sciences, An-Najah National University, Nablus, Palestine
Adwan K.M.
Department of Biological Sciences, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Department of Biology, Faculty of Science, An-Najah National University, Nablus. Palestine
Jarrar N.R.
Department of Biological Sciences, An-Najah National University, Nablus, Palestine
Budair M.M.
Department of Biological Sciences, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

The present study was initiated to assess and evaluate antimicrobial resistance in one hundred eighteen isolates of Shiga toxigenic Escherichia coli STEC O157 obtained from Northern Palestine. Eighty-three percent of isolates were resistant to ampicillin, followed by 59% to norfloxacin, 58% to tetracycline, 55% to gentamicin, 50% to chloramphinicol, 48% to amikacin, 40% to co-trimoxazole, and 25% to ceftazidime. Multidrug resistance was seen in more than two-third of the isolates (68%), and there was no common resistance pattern among the isolates. Our findings suggest that use of antimicrobials, including tetracycline derivatives, sulfa drugs, aminoglycosides, and penicillins, has selected for multiple antimicrobial resistance phenotypes in STEC O157.

AttachmentSize
9-Antimicrobial resistance of Shiga toxin-producing Escherichia coli O157 isolates from Northern Palestine.pdf343.09 KB